GSK Reaches Settlement in Two Calif. Zantac Cancer Cases




ALAMEDA, Calif. — GlaxoSmithKline has announced that it reached settlements in two bellwether California state court actions in which the plaintiffs alleged that its popular antacid Zantac (ranitidine) was contaminated with high levels of N-Nitrosodimethylamine (NDMA), a potent carcinogen, causing them to develop cancer.

The cases are still pending in the Alameda County Superior Court against co-defendant Boehringer Ingelheim and trial is set to begin before Judge Noel Wise, with jury selection on Sept. 30. Opening statements are scheduled for Oct. 7.

Plaintiffs John Russell and Annette Hughes allege they used Zantac regularly, and that the drug’s high levels of …






UPCOMING CONFERENCES




HarrisMartin's MDL Conference

December 04, 2024 - New York, NY
Virgin Hotels NYC

MORE DETAILS



HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS